Collaboration over at least three years aims to help understand how pre-cancerous cells develop
Business live – latest updates
GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.
The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.
More Stories
From the Beatles to biologics – how Liverpool became a life science hotspot
‘A neural fossil’: human ears try to move when listening, scientists say
All in the mind? The surprising truth about brain rot